NMPA Approval

Compound Sodium Lactate and Sorbitol Injection

Approval Number

国药准字H20205053

Company广东大冢制药有限公司

Registration Date

December 10, 2020

Previous Approval Numbers

国药准字H44020194

Drug Information

Generic Name

复方乳酸钠山梨醇注射液

Dosage Form

注射剂

Strength

250ml

Drug Type

化学药品

Registration Date

December 10, 2020

Company Information

Applicant Company

Company Name广东大冢制药有限公司

Company Address

广东省佛山市顺德区容桂街道市高新技术产业开发园

Manufacturing Company

Company Name广东大冢制药有限公司

Company Address

广东省佛山市顺德区容桂街道市高新技术产业开发园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

复方乳酸钠山梨醇注射液 - NMPA 批准文号 | MedPath